Literature DB >> 2338631

Mechanism and kinetics of secretion degradation in aqueous solutions.

T Tsuda1, M Uchiyama, T Sato, H Yoshino, Y Tsuchiya, S Ishikawa, M Ohmae, S Watanabe, Y Miyake.   

Abstract

In order to clarify the mechanism of secretin degradation in aqueous solutions, the formation of degradation products from secretin, aspartoyl3 secretin and beta-aspartyl3 secretin was investigated; the stabilities of these three peptides were investigated as well. Aspartoyl3 secretion and beta-aspartyl3 secretin, degradation peptides produced during the storage of secretin in aqueous solutions, were isolated by preparative reversed-phase HPLC (RP-HPLC). The amounts of secretin and its two degradation peptides resulting from storage of secretin in various buffer solutions (pH 2.3 to 10.0, mu = 0.5 M, 60 degrees C) were determined by analytical RP-HPLC. Secretin and the isolated degradation peptides were stored separately in various aqueous buffer solutions resulting in the degradation of each peptide. A mixture of secretin and its degradation or cleavage peptides was formed in each solution. The observed degradation rates for each peptide approximately followed first-order kinetics. The pH-rate profiles for conversion of secretin and beta-aspartyl3 secretin were similar, while that for aspartoyl3 secretin was different from these two. Aspartoyl3 secretin was more stable than the others at pH 2.3 to 4.0, but it was easily degraded between pH 5.0 and 10.0. Investigation of aspartoyl3 secretin degradation showed that its degradation was related to the pH value of the solution, and that hydroxide ion catalyzes the ring opening of the aspartoyl peptide. Secretin was most stable in pH 7.0 buffer solution and more stable in acidic solutions than in alkaline solutions. Secretion was mainly degraded through the following pathways: cleavage peptides reversible secretin in equilibrium aspartoyl peptide in equilibrium beta-aspartyl peptide vector cleavage peptides.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2338631     DOI: 10.1002/jps.2600790309

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Chemical pathways of peptide degradation. IV. Pathways, kinetics, and mechanism of degradation of an aspartyl residue in a model hexapeptide.

Authors:  C Oliyai; R T Borchardt
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

2.  Major degradation products of basic fibroblast growth factor: detection of succinimide and iso-aspartate in place of aspartate.

Authors:  Z Shahrokh; G Eberlein; D Buckley; M V Paranandi; D W Aswad; P Stratton; R Mischak; Y J Wang
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

3.  Inactivation kinetics of enzyme pharmaceuticals in aqueous solution.

Authors:  S Yoshioka; K Izutsu; Y Aso; Y Takeda
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.